Bank of America’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-36,592
| Closed | -$25.5K | – | 7068 |
|
|
2023
Q1 | $25.5K | Buy |
36,592
+18,321
| +100% | +$12.8K | ﹤0.01% | 5874 |
|
|
2022
Q4 | $16.4K | Sell |
18,271
-224
| -1% | -$202 | ﹤0.01% | 5991 |
|
|
2022
Q3 | $111K | Buy |
+18,495
| New | +$111K | ﹤0.01% | 5481 |
|
|
2022
Q1 | – | Sell |
-4,297
| Closed | -$19K | – | 7901 |
|
|
2021
Q4 | $19K | Buy |
+4,297
| New | +$19K | ﹤0.01% | 6673 |
|
|
2021
Q3 | – | Sell |
-1,903
| Closed | -$13K | – | 7488 |
|
|
2021
Q2 | $13K | Sell |
1,903
-5,932
| -76% | -$40.5K | ﹤0.01% | 6429 |
|
|
2021
Q1 | $46K | Buy |
7,835
+3,843
| +96% | +$22.6K | ﹤0.01% | 5975 |
|
|
2020
Q4 | $18K | Buy |
3,992
+908
| +29% | +$4.09K | ﹤0.01% | 5844 |
|
|
2020
Q3 | $12K | Sell |
3,084
-3,125
| -50% | -$12.2K | ﹤0.01% | 5753 |
|
|
2020
Q2 | $179K | Buy |
6,209
+2,530
| +69% | +$72.9K | ﹤0.01% | 4779 |
|
|
2020
Q1 | $79K | Buy |
3,679
+2,978
| +425% | +$63.9K | ﹤0.01% | 5065 |
|
|
2019
Q4 | $14K | Buy |
+701
| New | +$14K | ﹤0.01% | 5746 |
|